Preferred Label : Immunodeficiency 17;
Symbol : IMD17;
CISMeF acronym : IMD17;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Scid-like immunodeficiency, t cell-partial, b cell-positive, nk cell-positive; Cd3-gamma deficiency;
Description : Immunodeficiency-17 is an autosomal recessive primary immunodeficiency characterized
by highly variable clinical severity. Some patients have onset of severe recurrent
infections in early infancy that may be lethal, whereas others may be only mildly
affected or essentially asymptomatic into young adulthood. More severely affected
patients may have evidence of autoimmune disease or enteropathy. The immunologic pattern
is similar among patients, showing partial T-cell lymphopenia, particularly of cytotoxic
CD8 (see 186910)-positive cells, decreased amounts of the CD3 complex, and impaired
proliferative responses to T-cell receptor (TCR)-dependent stimuli. B cells, natural
killer (NK) cells, and immunoglobulins are usually normal. Although thymic output
of functional naive T cells early in life is decreased, polyclonal expansion of functional
memory T cells is substantial. The phenotype in some patients is reminiscent of severe
combined immunodeficiency (SCID) (summary by Timon et al. (1993) and Recio et al.
(2007)).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the CD3 antigen, gamma subunit gene (CD3G, 186740.0001);
Prefixed ID : #615607;
Origin ID : 615607;
UMLS CUI : C3810107;
Automatic exact mappings (from CISMeF team)
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)